Alert detail
FDA Approval: SPRAVATO (ESKETAMINE HYDROCHLORIDE) — Type 2 - New Active Ingredient
Policy ID: FDA-NDA211243Specialty: Multi-specialtyAdded: 6/27/2026Effective: 2019-03-05federal register
Full alert analysis requires a subscription
Subscribe to access the complete alert summary, AI-generated action recommendations, source document links, LCD revision comparisons, and related alerts.